Latest University of Texas Stories
An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report in the May 18 issue of The Lancet.
A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting.
Breast cancer stem cells wear a cell surface protein that is part nametag and part bull's eye, identifying them as potent tumor-generating cells and flagging their vulnerability to a drug.
A genetic mutation that drives the initiation of pancreatic cancer also manipulates metabolic pathways to support tumor growth and progression.
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors.
Bed bugs were discovered in the University of Texas in San Antonio for the fourth time.
Identification of a non-traditional pathway for spiriting a cancer-promoting protein into the cell nucleus points to a possible combination therapy for esophageal cancer and indicates a mechanism of resistance for new drugs that attack the Hedgehog pathway.
Chemists have developed a new origami-inspired paper sensor that can reportedly test for malaria, HIV, and other diseases and costs less than a dime per unit.
Michael Baker is an engineer and a retired United States Navy captain and NASA astronaut. He was born Michael Allen Baker on October 27, 1953 in Memphis, Tennessee, though he considers Lemoore, California to be his hometown. As a child he was active in the Boy Scouts of America. He graduated from Lemoore Union High School in 1971 and received a Bachelor of Science degree in aerospace engineering from the University of Texas in 1975. After his graduation, Baker completed flight training and...